Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 30 years and older, ECDC multi-country study – second update
- European Centre for Disease Prevention and Control
- , ECDC COVID-19 vaccine effectiveness hospital study participants
- , Nassera Aouali
- , F. Berthet
- , P. Braquet
- , G. Fagherazzi
- , M. Simon
Research output: Book/Report › Commissioned report › peer-review
74
Downloads
(Pure)